Contents

Current Gene Therapy, Volume 17 - Number 4

Biography

Meet Our Editorial Board Member

, 17(4): 259 - 260

Michele Simonato


DOI: 10.2174/156652321704180104153220




Editorial

Editorial: CRISPR Medicine: From Bench to Bedside

, 17(4): 261 - 262

Graham Dellaire


DOI: 10.2174/156652321704180104153508




Review Article

CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo

, 17(4): 263 - 274

Jayme Salsman, Jean-Yves Masson, Alexandre Orthwein* and Graham Dellaire*


DOI: 10.2174/1566523217666171122094629




Review Article

CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery

, 17(4): 275 - 285

Francis Robert, Sidong Huang and Jerry Pelletier*


DOI: 10.2174/1566523217666171121164615




Review Article

New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish

, 17(4): 286 - 300

Sergey V. Prykhozhij , Lucia Caceres and Jason N. Berman


DOI: 10.2174/1566523217666171121164132




Review Article

Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy

, 17(4): 301 - 308

Tatianna Wai Ying Wong and Ronald D. Cohn*


DOI: 10.2174/1566523217666171121165046




Research Article

First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

, 17(4): 309 - 319

Francoise Baylis* and Marcus McLeod


DOI: 10.2174/1566523217666171121165935




Review Article

The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy

, 17(4): 320 - 326

Yong Zhang, Zhen Tian, Jiajia Yuan, Chang Liu, Hong li Liu, Si Qi Ma and Bin Li*


DOI: 10.2174/1566523218666171129204926




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science